Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Los

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|August 10, 2005
Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous systemKristin Hauff, Christina Zamzow, Warren J Law, et al.
Journal of Cell Science|September 24, 2005
Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathwaySubbareddy Maddika, Evan P Booy, Dina Johar, et al.
Cancer Biology & Therapy|January 18, 2006
Cancer-selective therapy of the future: apoptin and its mechanism of actionSubbareddy Maddika, Francisco J Mendoza, Kristin Hauff, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 12, 2005
Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targetsFrancisco J Mendoza, Paula S Espino, Kendra L Cann, et al.
Molecular and Cellular Biology|December 24, 2008
Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicitySubbareddy Maddika, Soumya Panigrahi, Emilia Wiechec, et al.
Biochimica Et Biophysica Acta|April 21, 2009
Apoptin, a tumor-selective killerMarek Los, Soumya Panigrahi, Iran Rashedi, et al.
Plos Pathogens|October 8, 2013
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cellsDipu Mohan Kumar, Mamoru Yamaguchi, Koshiro Miura, et al.
Advanced Healthcare Materials|April 30, 2016
Direct Mechanical Stimulation of Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue EngineeringAmy Gelmi, Artur Cieslar-Pobuda, Ebo de Muinck, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 15, 2003
Viral modulation of cell death by inhibition of caspasesUwe Cassens, Grzegorz Lewinski, Ajoy K Samraj, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|May 5, 2023
Molecular mechanisms of microRNAs in glioblastoma pathogenesisAmir Barzegar Behrooz, Hamid Latifi-Navid, Akram Nezhadi, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Archivum Immunologiae Et Therapiae Experimentalis|August 10, 2005
Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous systemKristin Hauff, Christina Zamzow, Warren J Law, et al.
Journal of Cell Science|September 24, 2005
Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathwaySubbareddy Maddika, Evan P Booy, Dina Johar, et al.
Cancer Biology & Therapy|January 18, 2006
Cancer-selective therapy of the future: apoptin and its mechanism of actionSubbareddy Maddika, Francisco J Mendoza, Kristin Hauff, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 12, 2005
Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targetsFrancisco J Mendoza, Paula S Espino, Kendra L Cann, et al.
Molecular and Cellular Biology|December 24, 2008
Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicitySubbareddy Maddika, Soumya Panigrahi, Emilia Wiechec, et al.
Biochimica Et Biophysica Acta|April 21, 2009
Apoptin, a tumor-selective killerMarek Los, Soumya Panigrahi, Iran Rashedi, et al.
Plos Pathogens|October 8, 2013
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cellsDipu Mohan Kumar, Mamoru Yamaguchi, Koshiro Miura, et al.
Advanced Healthcare Materials|April 30, 2016
Direct Mechanical Stimulation of Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue EngineeringAmy Gelmi, Artur Cieslar-Pobuda, Ebo de Muinck, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 15, 2003
Viral modulation of cell death by inhibition of caspasesUwe Cassens, Grzegorz Lewinski, Ajoy K Samraj, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|May 5, 2023
Molecular mechanisms of microRNAs in glioblastoma pathogenesisAmir Barzegar Behrooz, Hamid Latifi-Navid, Akram Nezhadi, et al.
Pageof 6